Experiences from treatment-predictive KRAS testing; high mutation frequency in rectal cancers from females and concurrent mutations in the same tumor
-
* Corresponding author: Mef Nilbert mef.nilbert@med.lu.se
BMC Clinical Pathology 2009, 9:8 doi:10.1186/1472-6890-9-8
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 15 Jun 2009 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 07 Jul 2009 |
| Reviewer's Report | Kentaro Nakayama | 16 Aug 2009 | |
| Reviewer's Report | Joanne Young | 18 Aug 2009 | |
| Reviewer's Report | Johan van Krieken | 20 Aug 2009 | |
| Resubmission - Version 3 | Manuscript | Author's comment | 02 Sep 2009 |
| Resubmission - Version 4 | Manuscript | Author's comment | 21 Sep 2009 |
| Editorial acceptance | 23 Sep 2009 | ||
| Published | 15 Oct 2009 |